Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Di Fazio

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
European Review for Medical and Pharmacological Sciences|April 20, 2021
Cognitive function modulation during aging: a focus on L-alpha-GPEG Biggio, I Di Fazio, C Martini
European Journal of Clinical Pharmacology|September 11, 2001
Use of interleukin-2 in advanced renal carcinoma: meta-analysis and review of the literatureM Malaguarnera, L Ferlito, G Gulizia, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 30, 2001
Alpha-interferon (IFN-alpha) treatment of chronic hepatitis C: analysis of some predictive factors for the responseM Malaguarnera, I Di Fazio, B A Trovato, et al.
Archives of Gerontology and Geriatrics|September 18, 2004
On the importance of multidimensional evaluation of elderly oncologic patientsS Di Mauro, A Distefano, I Di Fazio, et al.
Neuropsychobiology|November 14, 1998
Tacrine treatment of Alzheimer's disease: many expectations, few certaintiesM Malaguarnera, G Pistone, M Vinci, et al.
Panminerva Medica|November 24, 1999
Haematologic pattern in healthy elderly subjectsM Malaguarnera, I Di Fazio, E Vinci, et al.
Minerva Medica|October 25, 2001
Lipoprotein (a) behaviour in patients with hepatocellular carcinomaM Motta, I Giugno, P Ruello, et al.
Archives of Gerontology and Geriatrics|January 1, 1996
Assessment of self-sufficiency in ultraoctageneriansM Malaguarnera, G Pistone, M Motta, et al.
Neuropsychobiology|May 5, 1998
Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alphaM Malaguarnera, I Di Fazio, S Restuccia, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Serum carnitine levels in chronic hepatitis C patients before and after lymphoblastoid interferon-alpha treatmentM Malaguarnera, S Restuccia, I Di Fazio, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
European Review for Medical and Pharmacological Sciences|April 20, 2021
Cognitive function modulation during aging: a focus on L-alpha-GPEG Biggio, I Di Fazio, C Martini
European Journal of Clinical Pharmacology|September 11, 2001
Use of interleukin-2 in advanced renal carcinoma: meta-analysis and review of the literatureM Malaguarnera, L Ferlito, G Gulizia, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 30, 2001
Alpha-interferon (IFN-alpha) treatment of chronic hepatitis C: analysis of some predictive factors for the responseM Malaguarnera, I Di Fazio, B A Trovato, et al.
Archives of Gerontology and Geriatrics|September 18, 2004
On the importance of multidimensional evaluation of elderly oncologic patientsS Di Mauro, A Distefano, I Di Fazio, et al.
Neuropsychobiology|November 14, 1998
Tacrine treatment of Alzheimer's disease: many expectations, few certaintiesM Malaguarnera, G Pistone, M Vinci, et al.
Panminerva Medica|November 24, 1999
Haematologic pattern in healthy elderly subjectsM Malaguarnera, I Di Fazio, E Vinci, et al.
Minerva Medica|October 25, 2001
Lipoprotein (a) behaviour in patients with hepatocellular carcinomaM Motta, I Giugno, P Ruello, et al.
Archives of Gerontology and Geriatrics|January 1, 1996
Assessment of self-sufficiency in ultraoctageneriansM Malaguarnera, G Pistone, M Motta, et al.
Neuropsychobiology|May 5, 1998
Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alphaM Malaguarnera, I Di Fazio, S Restuccia, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Serum carnitine levels in chronic hepatitis C patients before and after lymphoblastoid interferon-alpha treatmentM Malaguarnera, S Restuccia, I Di Fazio, et al.
Pageof 3